載入...
Estrogen Inhibition Reverses Pulmonary Arterial Hypertension and Associated Metabolic Defects
Increased estrogen is a strong epidemiologic risk factor for development of pulmonary arterial hypertension (PAH) in patients, associated with metabolic defects. Estrogens also drive penetrance in mice carrying mutations in BMPR2, the cause of most heritable PAH. The goal of the present study was to...
Na minha lista:
| 發表在: | Eur Respir J |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6532788/ https://ncbi.nlm.nih.gov/pubmed/28775043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.02337-2016 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|